Speakers

2021 Co-Chairs

Dominic Adair

Partner
Bristows LLP (U.K)

Doctrine of Equivalents Applied: Analyzing the Effects of Recent Decisions on Litigation Strategies in the UK and Across Europe

February 25, 2021 • 2:15 pm

Bert Oosting

Partner
Hogan Lovells

Arrow Declarations and Cross-Border Measures for Relief: Evaluating the Expanding Reach of Their Application

February 23, 2021 • 4:00 pm

Association Insights From

Monika Dorda

SVP & General Counsel Global Pharmaceuticals
GSK

Biologics and Biosimilars: Global Patent Litigation Strategies for Success

February 24, 2021 • 4:15 pm

Karin Hessler

Vice President and Deputy General Counsel
Association for Accessible Medicines (AAM)

Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel Coronavirus

February 23, 2021 • 12:30 pm

James Horgan

Head of European Patents Intellectual Property Department, Merck Sharp & Dohme Corp.
Member of IP Working Group EFPIA

Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel Coronavirus

February 23, 2021 • 12:30 pm

David E. Korn

Vice President, Intellectual Property and Law
Pharmaceutical Research and Manufacturers of America (PhRMA)

Biologics and Biosimilars: Global Patent Litigation Strategies for Success

February 24, 2021 • 4:15 pm

Andrea Pucci

Senior Legal & Compliance Advisor
Medicines for Europe

The Evolution of Safe Harbours and Patent Exemptions in Europe and The United States: Understanding the Expanding Reformation to Patent Infringement

February 23, 2021 • 1:30 pm

Hans Sauer, Ph.D., J.D.

Deputy General Counsel, Vice President for Intellectual Property
Biotechnology Innovation Organization (BIO)

A Study in Carve Outs Post-GSK v. Teva: Contrasting the Approach in the U.S. and Europe

February 24, 2021 • 1:15 pm

Hear from Government

Rainer Becker

Head of Unit, DG Competition
European Commission

Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic Considerations

February 25, 2021 • 3:15 pm

Hon. Jacqueline Wright Bonilla

Deputy Chief, Administrative Patent Judge
USPTO Patent Trial and Appeal Board

Virtual Opposition Proceedings Before the EPO, the Appeal Court of the Hague and in the PTAB

February 23, 2021 • 5:30 pm

Gordon Humphreys

Chairperson of the 2nd Board of Appeal
European Union Intellectual Property Office

Effectively Managing Global Pharmaceutical and Biotech Patent Litigation

February 24, 2021 • 12:15 pm

Aliki Nichogiannopoulou

Director
European Patent Office

Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel Coronavirus

February 23, 2021 • 12:30 pm

André Pohlmann

Member of the 5th Board of Appeal
European Union Intellectual Property Office

Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel Coronavirus

February 23, 2021 • 12:30 pm

Heli Pihlajamaa

Director
European Patent Office

Virtual Opposition Proceedings Before the EPO, the Appeal Court of the Hague and in the PTAB

February 23, 2021 • 5:30 pm

Industry Acumen From

Sara Burghart

Lead IP Litigation Counsel
Global Litigation & Launch – Global IP
Sandoz International GmbH (DEU)

Doctrine of Equivalents Applied: Analyzing the Effects of Recent Decisions on Litigation Strategies in the UK and Across Europe

February 25, 2021 • 2:15 pm

Monika Dorda

SVP & General Counsel Global Pharmaceuticals
GSK

Biologics and Biosimilars: Global Patent Litigation Strategies for Success

February 24, 2021 • 4:15 pm

Beatriz Diaz de Ezcauriaza

Head of IP Legal
Insud Pharma

Proportionality, Preliminary Injunctions & Damages: The Ability to Deny, Grant or Tailor Injunctive Relief

February 23, 2021 • 3:00 pm

James Horgan

Head of European Patents Intellectual Property Department, Merck Sharp & Dohme Corp.
Member of IP Working Group EFPIA

Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel Coronavirus

February 23, 2021 • 12:30 pm

Guido Pontremoli, Ph.D.

Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.

Effectively Managing Global Pharmaceutical and Biotech Patent Litigation

February 24, 2021 • 12:15 pm

Laura Reynolds

Associate General Counsel
European IP and Regulatory Litigation
Teva Pharmaceuticals

BREXIT and Supplementary Protection Certificates

February 25, 2021 • 12:15 pm

Dr. Corinna Sundermann

Senior Vice President Intellectual Property Management
Fresenius Kabi Deutschland GmbH

Virtual Opposition Proceedings Before the EPO, the Appeal Court of the Hague and in the PTAB

February 23, 2021 • 5:30 pm

Dr. Dean Thomas

Vice President - Global Head of IP and Associate General Counsel
Ichnos Sciences

The Evolution of Safe Harbours and Patent Exemptions in Europe and The United States: Understanding the Expanding Reformation to Patent Infringement

February 23, 2021 • 1:30 pm

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron Pharmaceuticals

Biologics and Biosimilars: Global Patent Litigation Strategies for Success

February 24, 2021 • 4:15 pm

Willem F.C. de Weerd

Director, Corporate Patent Counsel Patents Healthcare
Merck

A Study in Carve Outs Post-GSK v. Teva: Contrasting the Approach in the U.S. and Europe

February 24, 2021 • 1:15 pm

Esteemed Faculty

Dr. Jennifer Antcliff

Partner
Carpmaels & Ransford

A Study in Carve Outs Post-GSK v. Teva: Contrasting the Approach in the U.S. and Europe

February 24, 2021 • 1:15 pm

Thorsten Bausch

Partner
Hoffman Eitle

Proportionality, Preliminary Injunctions & Damages: The Ability to Deny, Grant or Tailor Injunctive Relief

February 23, 2021 • 3:00 pm

Koen Bijvank

Partner
Brinkhof Advocaten

Arrow Declarations and Cross-Border Measures for Relief: Evaluating the Expanding Reach of Their Application

February 23, 2021 • 4:00 pm

Pedro Callol

Founding Partner
CALLOL, COCA & ASOCIADOS, SLP

Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic Considerations

February 25, 2021 • 3:15 pm

Brian D. Coggio

Of Counsel
Fish & Richardson

The Evolution of Safe Harbours and Patent Exemptions in Europe and The United States: Understanding the Expanding Reformation to Patent Infringement

February 23, 2021 • 1:30 pm

Jules Fabre

Legal Director
Pinsent Masons

Doctrine of Equivalents Applied: Analyzing the Effects of Recent Decisions on Litigation Strategies in the UK and Across Europe

February 25, 2021 • 2:15 pm

Dr Penny Gilbert

Partner
Powell Gilbert LLP

Regeneron v. Kymab and The Lack of Sufficiency: A Game of Cat and Mouse Crescendos

February 24, 2021 • 3:15 pm

Professor Dr. Maximilian Haedicke

Professor of Intellectual Property Law
Freiburg University (DEU)
(Former Judge at higher Regional Court of Duesseldorf)

Proportionality, Preliminary Injunctions & Damages: The Ability to Deny, Grant or Tailor Injunctive Relief

February 23, 2021 • 3:00 pm

Dr. Jochen Herr LL.M.

Partner
Baker McKenzie

Doctrine of Equivalents Applied: Analyzing the Effects of Recent Decisions on Litigation Strategies in the UK and Across Europe

February 25, 2021 • 2:15 pm

Nicole Jadeja

Partner
Pinsent Masons

Regeneron v. Kymab and The Lack of Sufficiency: A Game of Cat and Mouse Crescendos

February 24, 2021 • 3:15 pm

Daan de Lange

Partner
Brinkhof Advocaten

Proportionality, Preliminary Injunctions & Damages: The Ability to Deny, Grant or Tailor Injunctive Relief

February 23, 2021 • 3:00 pm

Tom Leonard

Partner
Kilburn & Strode LLP

Regeneron v. Kymab and The Lack of Sufficiency: A Game of Cat and Mouse Crescendos

February 24, 2021 • 3:15 pm

Marie Manley

Partner
Sidley Austin LLP

BREXIT and Supplementary Protection Certificates

February 25, 2021 • 12:15 pm

Benjamin May

Partner
ARAMIS Société d'Avocats

Effectively Managing Global Pharmaceutical and Biotech Patent Litigation

February 24, 2021 • 12:15 pm

Roberto Ribeiro

Partner
Daniel Advogados

Biologics and Biosimilars: Global Patent Litigation Strategies for Success

February 24, 2021 • 4:15 pm

Jonathan E. Singer

Principal
Fish & Richardson

Virtual Opposition Proceedings Before the EPO, the Appeal Court of the Hague and in the PTAB

February 23, 2021 • 5:30 pm

Dr. Beatriz San Martin

Partner
Arnold & Porter

Arrow Declarations and Cross-Border Measures for Relief: Evaluating the Expanding Reach of Their Application

February 23, 2021 • 4:00 pm

Erin M. Sommer, Ph.D.

Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Effectively Managing Global Pharmaceutical and Biotech Patent Litigation

February 24, 2021 • 12:15 pm

Blaz Visnar

Administrator
European Commission

Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic Considerations

February 25, 2021 • 3:15 pm